Biophotonics Market Forecast 2024 to 2032
Biophotonics is an
interdisciplinary field that combines biology, physics, chemistry, and optics
to study and manipulate biological systems using light. It involves the
interaction of light with biological materials, ranging from single molecules
to entire organisms. The primary goal of biophotonics is to develop new
techniques and technologies for understanding biological processes, diagnosing
diseases, and advancing medical treatments.
The Biophotonics Market was
valued at USD 3,684.82 Million in 2022 and is expected to register a CAGR of
6.61% by 2032.
Biophotonics plays a
crucial role in improving medical imaging and diagnostics. Technologies such as
optical coherence tomography (OCT), multiphoton microscopy, and fluorescence
imaging offer high-resolution and non-invasive visualization of tissues and
cells. The demand for better diagnostic tools and imaging techniques has driven
the adoption of biophotonics solutions in medical settings. This key factor is
expected to drive global market growth during the forecast period.
By Market Vendors:
Carl Zeiss
Olympus
Hamamatsu Photonics
EndraLife Sciences
HORIBA
Newport
PerkinElmer
TILL Photonics
Zecotek Photonics
By Types:
In-Vivo
In-Vitro
By Applications:
See-Through Imaging
Inside Imaging
Spectromolecular
Surface Imaging
Microscopy
Light Therapy
Biosensors
.png)
.png)
No comments:
Post a Comment